Streetbeat News

Equity Actions

XHR

Xenia Hotels & Resorts has updated its full year outlook for 2023, expecting an adjusted FFO per share of $1.42-$1.60. The company's forecast reflects macroeconomic uncertainty and does not account for any unanticipated impacts to the business or operations. The guidance also assumes no additional acquisitions, dispositions, equity issuances, or share and/or senior note repurchases.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:51 am

TT

Trane Technologies has raised its FY23 outlook, now expecting an adjusted EPS of $8.80 to $8.90, up from the previous estimate of $8.30 to $8.50. The company also anticipates a revenue growth of approximately 10% for the full year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:47 am

BG

Bunge has raised its FY23 adjusted EPS outlook to at least $11.75, up from the previous range of $11.00 - $11.80, and above the $11.68 estimate. The company also expects a 2023 adjusted annual effective tax rate of 20% to 24%, net interest expense of $350 to $370 million, capital expenditures of $1.0 to $1.2 billion, and depreciation and amortization of approximately $415 million.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:47 am

VAL

Valaris Ltd reported Q2 2023 revenues of $415.2 million, beating the consensus of $412.3 million. However, excluding reimbursable items, revenues decreased to $390 million due to fewer operating days for the jackup fleet. The company got new contracts and extensions, with an associated contract backlog of around $180 million, increasing to $3.0 billion. The company also repurchased $65 million of shares through June 30, 2023, and $94 million to date. The company's shares closed lower by 1.15% at $75.92 on Tuesday.

Portfolio Pulse from Lekha Gupta

August 04, 2023 | 10:44 am

APVO

Aptevo Therapeutics has priced a $5 million public offering of 8,064,517 shares at $0.62 per share. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:42 am

TARS

Tarsus Pharmaceuticals has announced the pricing of its $100M underwritten public offering of 5,714,285 shares of common stock at $17.50 per share.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:40 am

PTC

ROK

PTC has priced a public secondary offering of 5,830,905 common shares at $141.75 per share. The shares were sold by Rockwell Automation.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:40 am

APVO

Aptevo Therapeutics has announced the pricing of its $5M public offering of 8,064,517 shares of common stock at $0.62 per share.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:40 am

PRCT

PROCEPT BioRobotics has announced the pricing of its upsized public offering of approximately 4.4 million shares of common stock at $33.92 per share, raising around $150 million.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:40 am

CCL

CUK

Carnival Corporation has issued notices of redemption for $1.2 billion of debt. The company also announced the pricing of a $500 million 7.00% first-priority senior secured notes offering, and the upsizing and pricing of a $1.3 billion senior secured first lien term loan B facility.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:40 am